Manufactured by: Glenmark Pharmaceuticals Ltd, based in India
Marketing Authorization: The ointment is marketed in Malaysia under the MAL number MAL20030397AZ, indicating its approval by the Malaysian National Pharmaceutical Regulatory Agency (NPRA) .
Active Ingredient: Mupirocin 2% w/w (20 mg per gram)
Formulation: Ointment
Pack Size: 5 grams
Manufacturer: Glenmark Pharmaceuticals Ltd
Marketing Authorization: MAL20030397AZ (Malaysia)
Supirocin Ointment is indicated for the topical treatment of:
Impetigo
Folliculitis
Furunculosis
Secondary bacterial skin infections
Prevention of catheter exit-site infections
Dosage: Apply a thin layer to the affected area 2–3 times daily.
Duration: Typically used for 5–10 days; do not exceed 10 days.
Application: Clean and dry the affected area before application.
Precautions:
For external use only; avoid contact with eyes, nose, or mouth.
Do not apply to broken skin, extensive wounds, or burns.
Discontinue use if irritation occurs.
Consult a doctor if no improvement is observed within 3–5 days.
Malaysia
